SE7509394L - Forfarande for framstellning av substituerade azetidin-2-oner - Google Patents

Forfarande for framstellning av substituerade azetidin-2-oner

Info

Publication number
SE7509394L
SE7509394L SE7509394A SE7509394A SE7509394L SE 7509394 L SE7509394 L SE 7509394L SE 7509394 A SE7509394 A SE 7509394A SE 7509394 A SE7509394 A SE 7509394A SE 7509394 L SE7509394 L SE 7509394L
Authority
SE
Sweden
Prior art keywords
ones
procedure
preparation
substituted azetidin
azetidin
Prior art date
Application number
SE7509394A
Other languages
English (en)
Swedish (sv)
Inventor
J H C Nayler
M J Pearson
R Southgate
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB14172A external-priority patent/GB1355980A/en
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of SE7509394L publication Critical patent/SE7509394L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C07D205/095Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568Four-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SE7509394A 1971-07-16 1975-08-22 Forfarande for framstellning av substituerade azetidin-2-oner SE7509394L (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB14172A GB1355980A (en) 1971-07-16 1971-07-16 Substituted azetidin-2-ones
GB14172 1972-01-03
GB1869272 1972-04-21

Publications (1)

Publication Number Publication Date
SE7509394L true SE7509394L (sv) 1975-08-22

Family

ID=27253667

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7509394A SE7509394L (sv) 1971-07-16 1975-08-22 Forfarande for framstellning av substituerade azetidin-2-oner
SE7509395A SE7509395L (sv) 1971-07-16 1975-08-22 Forfarande for framstellning av substituerade azetidin-2-oner

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7509395A SE7509395L (sv) 1971-07-16 1975-08-22 Forfarande for framstellning av substituerade azetidin-2-oner

Country Status (8)

Country Link
AU (1) AU4219672A (es)
BE (1) BE783298A (es)
CA (1) CA971570A (es)
DE (1) DE2222924A1 (es)
ES (3) ES402958A1 (es)
FR (1) FR2146212A1 (es)
NL (1) NL7206371A (es)
SE (2) SE7509394L (es)

Also Published As

Publication number Publication date
SE7509395L (sv) 1975-08-22
FR2146212A1 (en) 1973-03-02
DE2222924A1 (de) 1973-01-25
ES431709A1 (es) 1977-04-16
NL7206371A (es) 1973-01-18
CA971570A (en) 1975-07-22
ES402958A1 (es) 1975-10-16
AU4219672A (en) 1973-11-15
BE783298A (fr) 1972-11-10
ES431708A1 (es) 1977-04-16

Similar Documents

Publication Publication Date Title
SE392269B (sv) Forfarande for framstellning av vissa indanyloxitetrazoler
SE385891B (sv) Forfarande for framstellning av bensopyranforeningar
SE391126B (sv) Forfarande for framstellning av gasfria tandvardsmedel
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
SE400292B (sv) Forfarande for framstellning av benshydryl-3-karbamoyloximetyl-7-tienylacetamido-7-metoxidecefalosporanat
NO147916C (no) Fremgangsmaate for fremstilling av 3-metylen-cefalosporin-forbindelser.
SE417200B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE400764B (sv) Forfarande for framstellning av substituerade 3-hydroximetylisokinoliner
SE393615B (sv) Forfarande for framstellning av 6-metyl-8 beta-ureidometyl-ergolener
SE405478B (sv) Forfarande for framstellning av alfa-sulfoacylcefalosporiner
SE397090B (sv) Forfarande for framstellning av hydroxipyrimidiner
SE380815B (sv) Forfarande for framstellning av transparenta sampolyamider
SE412756B (sv) Alternativa forfarande for framstellning av 2-(aminofenylimino)-3-aza-1-tia-cykloalkaner
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE406587B (sv) Forfarande for framstellning av 4-hydroximetyl-1-keto-1,2-dihydroftalazin
SE386175B (sv) Forfarande for framstellning av 1,4-bis-acylpiperaziner
SE387936B (sv) Forfarande for framstellning av substituerade metoxiaminer
SE380520B (sv) Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin
SE398123B (sv) Forfarande for framstellning av metoximetylestern av hetacillin
SE390025B (sv) Forfarande for framstellning av 3 alfa-hydroxi-19-5 alfa-pregnan-11,20-dion
SE386897B (sv) Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler
SE392902B (sv) Forfarande for framstellning av fenylimidazolidinoner
SE404803B (sv) Analogiforfaranden for framstellning av pyrido-diazepiner
SE397350B (sv) Forfarande for framstellning av tieno-diazepinderivat
SE405730B (sv) Forfarande for framstellning av kinazolinderivat